THE Therapeutic Goods Administration (TGA) has fined a NSW-based individual $7,992, for allegedly advertising ivermectin and zinc lozenges to treat COVID-19, in breach of the Therapeutic Goods Act 1989.
The TGA has previously warned consumers and advertisers about illegal advertising relating to COVID-19.
"The individual allegedly claimed, on their website, that ivermectin and zinc lozenges are effective in the treatment of COVID-19," the TGA said.
Meanwhile, crossbench MP, Craig Kelly, criticised the TGA's decision to restrict "prescribing ivermectin through the Pharmaceutical Benefits Scheme (PBS) for COVID-19, denying sick Australians access to a medicine that many medical experts believe could save lives."
Kelly told the House of Representatives that the restrictions were related to supply shortages, but noted the TGA had not taken steps to boost supply.
The above article was sent to subscribers in Pharmacy Daily's issue from 30 Nov 21
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 30 Nov 21
